BioCentury | Aug 12, 2013
Clinical News

GIC-1001: Phase IIa started

...a tenth dose given once 2 hours prior to sedation-free colonoscopy in about 240 patients. gIcare pharma Inc....
BioCentury | Mar 18, 2013
Emerging Company Profile

gIcare: Colonoscopy comfort

...Hamilton, Ontario Cara Therapeutics Inc. , Shelton, Conn. Furiex Pharmaceuticals Inc. (NASDAQ:FURX), Morrisville, N.C. gIcare pharma Inc....
...N.J. Tioga Pharmaceuticals Inc. , San Diego, Calif. University of Perugia , Perugia, Italy Sidebars gIcare pharma Inc....
BioCentury | Jul 25, 2011
Financial News

gIcare pharma completes venture financing

gIcare pharma Inc. , Montreal, Quebec Business: Neurology, Gastrointestinal Date completed: 7/21/11 Type: Venture financing Raised: $7 million Investors: Forbion Capital Partners; Genesys Capital Partners WIR Staff Gastrointestinal Neurology...
Items per page:
1 - 3 of 3
BioCentury | Aug 12, 2013
Clinical News

GIC-1001: Phase IIa started

...a tenth dose given once 2 hours prior to sedation-free colonoscopy in about 240 patients. gIcare pharma Inc....
BioCentury | Mar 18, 2013
Emerging Company Profile

gIcare: Colonoscopy comfort

...Hamilton, Ontario Cara Therapeutics Inc. , Shelton, Conn. Furiex Pharmaceuticals Inc. (NASDAQ:FURX), Morrisville, N.C. gIcare pharma Inc....
...N.J. Tioga Pharmaceuticals Inc. , San Diego, Calif. University of Perugia , Perugia, Italy Sidebars gIcare pharma Inc....
BioCentury | Jul 25, 2011
Financial News

gIcare pharma completes venture financing

gIcare pharma Inc. , Montreal, Quebec Business: Neurology, Gastrointestinal Date completed: 7/21/11 Type: Venture financing Raised: $7 million Investors: Forbion Capital Partners; Genesys Capital Partners WIR Staff Gastrointestinal Neurology...
Items per page:
1 - 3 of 3